Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 8;14(7):e0218434. doi: 10.1371/journal.pone.0218434

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Herr et al

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Fig 3 — RFS (a) and OAS (b) of all Luminal A patients with > 3 affected lymph nodes stratified by tumor size and adjusted by therapy and age. In this group of > 3 affected lymph lodes, patients with tumors > 2cm have a significant worse survival (5-year RFS: T1 92,0%; T>2cm 81,2%; 5-year OAS T1 93,2%; T>2cm 82,1%), n = 469. RFS (c) and OAS (d) of only those of the total of 469 Luminal A patients with > 3 affected lymph nodes which had received adjuvant endocrine- and chemotherapy, stratified by tumor size and adjusted by therapy and age. In this group of > 3 affected lymph lodes, patients with tumors > 2cm have a significant worse survival (5-year RFS: T1 92,5%; T>2cm 82,0%; 5-year OAS T1 96,0%; T>2cm 87,8%), n = 335.